Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE is a small molecule identified as an inhibitor of Fructose 1,6-bisphosphatase 1 (FBPase-1). FBPase-1 is a key enzyme involved in gluconeogenesis, the metabolic pathway that results in the generation of glucose from non-carbohydrate carbon substrates. Inhibition of FBPase-1 can modulate glucose production, making such compounds of interest for metabolic disorders.
- Other names
- RefChem:4443202,5-dichloro-n-(5-chloro-1,3-benzoxazol-2-yl)benzene-1-sulfonamideFBPase-1 InhibitorFBPase1 InhibitorFBPase 1 InhibitorFBPase-1 inhibitor-1FBPase1 inhibitor-1FBPase 1 inhibitor-12,5-dichloro-N-(5-chlorobenzo[d]oxazol-2-yl)benzenesulfonamideCHEMBL207095CHEMBL-207095CHEMBL 207095Fructose 1,6-bisphosphatase-1 InhibitorFBPase-1FBPase1FBPase 15-Chloro-2-(N-(2,5-dichlorobenzenesulfonamido))-benzoxazole5F4H55S6YBFBPase-1 inhibitor compound 1FBPase1 inhibitor compound 1FBPase 1 inhibitor compound 1orb1306103orb-1306103orb 1306103SCHEMBL23752330SCHEMBL-23752330SCHEMBL 237523302,5-dichloro-N-(5-chloro-2-benzoxazolyl)benzenesulfonamideBDBM50181323BDBM-50181323BDBM 50181323MFCD22581250MFCD-22581250MFCD 22581250AKOS040744978AKOS-040744978AKOS 040744978DB07312DB-07312DB 07312BS-47308BS47308BS 47308DA-73315DA73315DA 73315HY-136717HY136717HY 1367172,5-BIS(CHLORANYL)-N-(5-CHLORANYL-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDEBenzenesulfonamide, 2,5-dichloro-N-(5-chloro-2-benzoxazolyl)-883973-99-7
02
Targets
FBP1 (Fructose-1,6-bisphosphatase 1)
Beyond the preview
Go deeper on 2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE.